论文部分内容阅读
目的:探讨糖皮质激素+特布他林用于慢性阻塞性肺疾病急性加重期患者治疗的疗效。方法:抽取我院2015年4月至2017年2月收治的慢性阻塞性肺疾病急性加重期患者62例为研究对象,以临床治疗所用药物分组:对照组31例行特布他林治疗,研究组31例行糖皮质激素+特布他林治疗,对比两组疗效及肺功能改善情况。结果:(1)研究组治疗总有效率明显高于对照组(P<0.05);(2)研究组治疗后FVC、FEV1、FEV1/FVC水平明显高于对照组(P<0.05)。结论:在特布他林基础上,给予慢性阻塞性肺疾病急性加重期患者糖皮质激素治疗,更利于改善肺功能,增强疗效,值得借鉴。
Objective: To investigate the efficacy of glucocorticoid + terbutaline in the treatment of patients with acute exacerbation of chronic obstructive pulmonary disease. Methods: Totally 62 patients with acute exacerbation of chronic obstructive pulmonary disease who were admitted to our hospital from April 2015 to February 2017 were enrolled in this study. The drugs used for clinical treatment were divided into three groups: control group (31 cases) treated with terbutaline Group 31 cases of glucocorticoid + terbutaline treatment, the two groups were compared efficacy and improvement of lung function. Results: (1) The total effective rate in study group was significantly higher than that in control group (P <0.05). (2) The FVC, FEV1 and FEV1 / FVC levels in study group were significantly higher than those in control group (P <0.05). CONCLUSIONS: On the basis of terbutaline, glucocorticoid treatment in patients with acute exacerbation of chronic obstructive pulmonary disease is more beneficial to improve lung function and enhance efficacy, which is worth learning from.